Publicaciones: Artículos

Hepatic safety of rilpivirine/emtricitabine/tenofovir disoproxil fumarate fixed-dose single-tablet regimen in HIV-infected patients with active hepatitis C virus infection: The hEPAtic Study. PLos One. 2016; 11:e0155842.

Neukam K, Espinosa N, Collado A, Delgado-Fernández M, Jiménez-Aguilar P, Rivero-Juárez A, Hotañón-Antoñano V, Gómez-Berrocal A, Ruiz-Morales J, Merino D, Carrero A, Téllez F, Ríos MJ, Hernández-Quero J, de Lagarde-Sebastián M, Fernández-Fuertes E, Vera-Méndez F, Macías J, Pineda JA, on behalf of the hEPAtic Study Group.